Current Cancer Therapy Reviews,
Journal Year:
2024,
Volume and Issue:
21(1), P. 54 - 75
Published: Jan. 17, 2024
:
The
second
most
prevalent
cause
of
fatalities
globally
is
malignant
tumors.
avoidance
and
therapy
cancer
proliferation
still
have
many
prospects
for
betterment
despite
enormous
advancements.
Chemotherapy
can
occasionally
a
lot
unfavorable
adverse
reactions.
Novel
agents
from
botanicals,
especially
the
use
therapeutic
ingredients,
may
decrease
negative
consequences.
There
are
currently
several
products
plants
used
fighting
cancer.
However,
numerous
plant
chemicals
not
yet
been
examined
in
people
but
show
extremely
encouraging
invitro
anti-cancer
properties.
Further
research
required
to
determine
whether
these
beneficial
treating
human
cancers.
present
work
has
focused
on
various
traditional
herbal
remedies
phytochemicals
that
exhibited
promising
anticancer
impact.
desirable
activity
be
due
novel
isolated
sources.
investigations
address
natural
ingredients
treatment
chemoprevention
now
being
clinical
settings
and/or
undergoing
studies.
Potential
concentrating
naturally
drugs
create
an
entirely
avenue
fight
against
could
significantly
boost
chance
survival
patients.
Drug Delivery and Translational Research,
Journal Year:
2024,
Volume and Issue:
14(11), P. 3089 - 3111
Published: March 2, 2024
Abstract
Hepatocellular
carcinoma
(HCC)
ranks
as
the
third
leading
cause
of
cancer-related
deaths
worldwide.
Current
treatment
strategies
include
surgical
resection,
liver
transplantation,
liver-directed
therapy,
and
systemic
therapy.
Sorafenib
(Sor)
is
first
drug
authorized
by
US
Food
Drug
Administration
(FDA)
for
HCC
treatment.
Nevertheless,
conventional
oral
administration
Sor
presents
several
limitations:
poor
solubility,
low
bioavailability,
resistance
development,
off-target
tissue
accumulation,
to
numerous
adverse
effects.
Nano-emulsion,
a
nano-delivery
system,
viable
carrier
poorly
water-soluble
drugs.
It
aims
enhance
target
organ
reduce
exposure,
thus
improving
therapeutic
outcomes
while
minimizing
side
This
study
formulated
nano-emulsion
(Sor
NanoEm)
using
homogenization
technique.
The
resultant
was
characterized
particle
size
(121.75
±
12
nm),
polydispersity
index
(PDI;
0.310),
zeta
potential
(-12.33
1.34
mV),
viscosity
(34,776
3276
CPs),
pH
(4.38
0.3).
Transmission
Electron
Microscopy
exhibited
spherical
nano-droplets
with
no
aggregation
signs
indicating
stability.
Furthermore,
encapsulation
within
sustained
its
release,
potentially
reducing
frequency
doses.
Cytotoxicity
assessments
on
HepG2
cell
line
revealed
that
NanoEm
had
significantly
(P
<
0.05)
more
potent
cytotoxic
effect
compared
suspension.
Subsequent
tests
highlighted
superior
pharmacokinetic
parameters
reduced
dosage
requirements
in
mice.
an
enhanced
safety
profile,
particularly
behavior,
brain,
liver,
suspended
form.
These
findings
underscore
pharmacological
toxicological
attributes
suggesting
utility
Graphical
abstract
Advances in Clinical Toxicology,
Journal Year:
2024,
Volume and Issue:
9(1), P. 1 - 8
Published: Jan. 1, 2024
Background:
Hepatocellular
carcinoma
(HCC)
is
a
prevalent
liver
cancer
with
major
risk
factors
being
hepatitis
viral
infections,
alcohol,
non-alcoholic
fatty
disease,
and
aflatoxin
exposure.
Both
genotoxic
non-genotoxic
agents
can
induce
HCC
through
mechanisms
involving
DNA
damage,
oxidative
stress,
chronic
inflammation,
disrupted
signaling
pathways
like
MAPK/ERK,
PI3K/AKT,
WNT/β-catenin
PPARα.
While
rodent
assays
are
utilized
to
detect
potential
chemical
hepatocarcinogens,
species
differences
in
PPARα
CAR/PXR
activation
impact
human
assessment.
Purpose:
This
analysis
provides
an
updated,
critical
examination
of
concordance
hepatic
carcinogenesis
inform
safety
assessment
tumor
findings.
Main
Body:
Rodent
including
2-year
bioassays,
transgenic
models,
short-term
studies
tumors
lifetime
exposure
or
early
biomarkers.
However,
rodent-specific
activation,
along
hepatitis,
highlight
key
interspecies
differences.
Determining
mode
action
relevance
requires
evaluating
mechanistic
validity
pivotal
events
leading
across
species.
Non-genotoxic
compounds
eliciting
activate
PPARα,
CAR/PXR,
other
triggering
increased
cell
replication;
but
downstream
may
differ
liver.
Understanding
applicability
these
humans
as
well
incorporating
into
experimental
models
for
accurate
Conclusion:
In
summary,
elucidating
conserved
versus
divergent
molecular
between
rodents
essential
appropriately
interpreting
findings
safeguarding
health
science-based
frameworks
regulatory
decision-making
processes
around
hazards.
Current Cancer Drug Targets,
Journal Year:
2024,
Volume and Issue:
24(12), P. 1235 - 1249
Published: Feb. 13, 2024
Hepatocellular
carcinoma
(HCC)
is
characterized
by
high
vascularity
and
notable
abnormality
of
blood
vessels,
where
angiogenesis
a
key
process
in
tumorigenesis
metastasis.
The
main
functions
Nei
Like
DNA
Glycosylase
3
(NEIL3)
include
alcoholization
repair,
immune
response
regulation,
nervous
system
development
function,
damage
signal
transduction.
However,
the
underlying
mechanism
expression
NEIL3
progression
HCC
whether
absence
or
silencing
inhibits
cancer
remain
unclear.
Therefore,
deeper
understanding
mechanisms
which
increased
promotes
needed.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(23), P. 7935 - 7935
Published: Dec. 4, 2023
Neurological-related
disorders
are
diseases
that
affect
the
body’s
neurons
or
peripheral
nerve
tissue,
such
as
Parkinson’s
disease
(PD)
and
Alzheimer’s
(AD).
The
development
of
neurological
can
cause
serious
harm
to
quality
life
functioning
patient.
use
traditional
therapeutic
agents
dopamine-promoting
drugs,
anticholinergic
cholinesterase
inhibitors,
NMDA
receptor
antagonists
is
often
accompanied
by
a
series
side
effects
drug
resistance,
cardiac
arrhythmia,
liver
function
abnormalities,
blurred
vision.
Therefore,
there
an
urgent
need
find
with
high
safety
profile
few
effects.
Herbal
medicines
rich
in
active
ingredients
natural
macromolecules.
Ginsenoside
main
ingredient
ginseng,
which
has
variety
pharmacological
considered
have
potential
value
treatment
human
diseases.
Modern
studies
shown
ginsenosides
Rg2
Rh1
strong
activities
nervous
system,
protective
on
cells,
improved
resistance
neuronal
injury,
modulation
neural
activity,
cerebral
ischemia/reperfusion
improvement
brain
damage
after
eclampsia
hemorrhage,
memory
cognitive
deficits,
AD
vascular
dementia,
alleviation
anxiety,
pain,
inhibition
ionic-like
behavior.
In
this
article,
we
searched
research
literature
field
diseases,
summarized
latest
progress
two
ginsenosides,
reviewed
mechanisms
Rh1,
provided
new
way
thinking
for
ginseng
anti-neurological
drugs.